🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hereditary cerebellar ataxias include diverse neurodegenerative disorde...
Status
Completed
Location
Center for Experimental Neurological Therapies (CENTERS), S. Andrea Hospital, II Faculty of Medicine, "Sapienza" University of Rome
Start Date
2010-04
Trial ID
NCT01104649
Treatments Being Tested
MIROCALS is a phase II study of ld-IL-2 as a therapeutic agent for ALS. A r...
Status
Completed
Location
CHRU de Lille - Hôpital Roger Salengro
Start Date
2017-06-19
Trial ID
NCT03039673
Treatments Being Tested
The goal of the current proposal is to examine if sublingual riluzole can r...
Status
Completed
Location
Connecticut Mental Health Center
Start Date
2017-01
Trial ID
NCT03017508
Spinocerebellar ataxia type 7 (SCA7) belongs to the dominant forms of inher...
Status
Recruiting
Location
Neurological Unit, S. Andrea Hospital, Faculty of Medicine and Psychology, "Sapienza" University of Rome
Start Date
2021-06-01
Trial ID
NCT03660917
Multiple sclerosis (MS) is a disabling and progressive neurological disease...
Status
Completed
Location
Anne Rowling Regenerative Neurology Clinic, Royal Infirmary of Edinburgh
Start Date
2014-12-18
Trial ID
NCT01910259
Treatments Being Tested
The objective is to compare the efficacy and safety of masitinib in combina...
Status
Completed
Location
Hospital Carlos III
Start Date
2013-04
Trial ID
NCT02588677
Treatments Being Tested
This is a single center, randomized, double-blind, placebo-controlled, 6-mo...
Status
Completed
Location
Carolinas Healthcare System, Dept. of Neurology
Start Date
2014-09
Trial ID
NCT02238626
Treatments Being Tested
The primary purpose is to determine if patients scheduled to receive prescr...
Status
Terminated
Location
UT Southwestern
Start Date
2005-11
Trial ID
NCT00283309
ATRIL is a multi-centric, double-blind randomized, two-arm controlled study...
Status
Completed
Location
Durr
Start Date
2018-01-17
Trial ID
NCT03347344
This study will examine the potential efficacy and safety of riluzole for c...
Status
Completed
Location
Offord Centre for Child Studies
Start Date
2013-09
Trial ID
NCT01661855